Enhancing the QUAlity and Transparency Of health Research

Visit the EQUATOR
Spanish Website

Reporting guidelines under development

The following guidelines are currently being developed:

*****

We encourage everyone to submit brief details about their reporting guideline under development for inclusion on the EQUATOR website. This will raise awareness about the development of your guideline and help to prevent duplication. To register your reporting guideline under development please complete our brief registration form (Word document).

*****

Guidelines for reporting the impact of patient and public involvement in research: Strengthening the evidence base of patient and public involvement

REporting Manualised INterventions for Dissemination and Evaluation (REMINDE) Statement

CONSORT Extension for Social and Psychological Interventions: CONSORT-SPI

An official extension of the CONSORT 2010 Statement for reporting randomised controlled trials of social and psychological interventions is currently under development. A Delphi process to generate possible reporting standards for the guideline will take place in Fall 2013. Interested stakeholders should contact the project team to get involved in the development and dissemination of the guideline.

STROBE checklist for conference abstracts

The STROBE Group have recently developed a checklist for conference abstracts.

CIRCLe SMT project (Consensus on Interventions Reporting Criteria List Spinal Manipulative Therapy)

Guideline for reporting evidence based practice educational interventions and teaching (GREET) statement

Guidelines for the Reporting of Neuro-Epidemiological Studies

This project aims to produce a set of quality criteria and comparable reporting guidance specifically for common neurological disorders.

Developing Standards for Reporting Phase IV Implementation studies (StaRI)

Development of a guideline to improve the quality of reporting of Phase IV implementation studies, specifically those with a comparator group.

eMERGe – Meta-ethnography Reporting Guidelines

Development of new guidelines for the reporting of meta-ethnography qualitative evidence syntheses.

STROBE-Nut: a STROBE extension for Nutrition Epidemiology

Development of a checklist that can be used to report nutrition epidemiology.

Preferred Reporting Of CasE SerieS (PROCESS) checklist

Case series make up a large portion of the medical literature. This project aims to develop a checklist and guidance document for authors to improve the quality of reporting case series. The literature search is currently ongoing.

Reporting Items for Guidelines in Health Systems (Right)

Development of essential reporting items for practice guidelines in health systems to ensure the comprehensive and transparent reporting of such guidelines.

Development of a reporting guideline for pilot and feasibility studies

Aim: To develop a reporting guideline for pilot and feasibility studies in preparation for a randomized controlled trial; as an extension to the CONSORT Statement.

Reporting Guidelines for IDEAL Prospective Development and Prospective Exploration Studies

The IDEAL (Idea, Development, Exploration, Assessment and Long term follow up) framework (1) allows for the phased and sequential development of a new surgical innovation, optimizing patient safety as the evidence-base builds in a controlled and purposeful manner.

These guidelines aim to improve the completeness of reports and protocols for IDEAL Prospective Development Studies (PDS – phase 2a) and Prospective Exploration Studies (PES – phase 2b).

1. McCulloch P, Altman DG, Campbell WB, et al, for the Balliol Collaboration. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009; 374: 1105–12.

Developing reporting guidelines for single-case experimental designs: the SCRIBE project

  • Read the SCRIBE project abstract
  • Contact: Dr Robyn Tate (rtate@med.usyd.edu.au), Professorial Research Fellow, Rehabilitation Studies Unit, Sydney Medical School, University of Sydney, Australia

Checklist for assessing the reporting of the updating methodology in updated guidelines

This project aims to develop a checklist to establish what information and how it should be presented in updated guidelines.

Checklist for the conduct and reporting of micro-costing studies in health care

Consort extension to stepped wedge cluster randomised controlled trial

To develop an extension to the reporting guideline for parallel cluster trials to produce recommended reporting guidelines for stepped wedge cluster randomised controlled trials.

CONSORT-equity: Improving the relevance of randomized controlled trials for equity-oriented decisions

An official extension of the CONSORT 2010 Statement for reporting equity focused randomised controlled trials is currently under development.

Development of a reporting guideline for reporting studies on time to diagnosis

Consensus on Exercise Reporting Template (CERT)

  • Authors/Steering Committee: Dr Susan Slade, Professor Rachelle Buchbinde, Professor Martin Underwoood, Professor Clermont Dionne.
  • Contact: Dr Susan Slade, susan.slade@monash.edu.au

SPIRIT Extension for trials in Child Health: SPIRIT-C

An official extension of the SPIRIT 2013 Statement defining standard protocol items for clinical trials in children is currently under development. A Delphi process to generate possible reporting standards for the guideline has taken place in Q2-3 2014. A Consensus meeting was held 15 September 2014.

CONSORT Extension for trials in Child Health: CONSORT-C

An official extension of the CONSORT 2010 Statement for reporting randomised controlled trials in children is currently under development. A Delphi process to generate possible reporting standards for the guideline has taken place in 2009-2010. A systematic review of the literature was conducted Q2-3 2014. A Consensus meeting was held 16 September 2014.

Preferred Reporting Items for Systematic reviews and Meta-Analysis – Reporting for Children (PRISMA-C)

An official extension of the PRISMA 2009 Statement defining standard reporting items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-C will take place in Q2/Q3 of 2015. We invite interested stakeholders to participate in the project by contacting the project team.

Preferred Reporting Items for Systematic reviews and Meta-Analysis – Protocols for Children (PRISMA-PC)

An official extension of the PRISMA-P Statement defining standard protocol items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-PC will take place in Q2/Q3 of 2015. We invite interested stakeholders to participate in the project by contacting the project team.

GATHER: Guidelines for Accurate and Transparent Health Estimates Reporting

GATHER defines best practices for documenting studies that report global health estimates. Global health estimates include all quantitative population-level estimates (including global, regional, national, or subnational estimates) of health indicators, including indicators of health status such as estimates of total and cause-specific mortality, incidence and prevalence of diseases and injuries; and indicators of health determinants, including health behaviours and health exposures.

CORE Reference Tool (Clarity and Openness in Reporting: E3-based)

A reference tool for use in conjunction with the 1996 ICH E3 (and subsequent relevant ICH) guidance, for clinical study report authoring. CORE Reference will provide clarity on existing guidance and practical solutions for upholding the principles of responsible clinical trial data sharing, to safeguard the anonymity of clinical trial participants.

SMARTER: Standard Medical Abortion Research Trial Efficacy Reporting

The SMARTER statement consists of a 12-item checklist and aims primarily to ensure appropriate reporting of the regimen used, number of women treated, number who had follow-up (outcome) data available, and outcomes by gestational age.  Reporting outcomes in a standard manner will ensure that data is available for better synthesis into evidence-based guidelines.

Adapting TIDieR checklist for reporting public health, health systems and social and environmental policy interventions (UNTIDieR)

Adapting TIDieR (Template for Intervention Description and Replication) checklist for reporting public health, health systems and social and environmental policy interventions with potential to affect population health which do not fit well within the existing TIDieR framework.

STARD for Abstracts: Essential items in reporting diagnostic accuracy studies in journal or conference abstracts

Diagnostic accuracy studies evaluate the ability of a diagnostic test to correctly identify patients as having or not having a particular disease. Readers of diagnostic accuracy study reports use abstracts to decide whether they should look for the full study report and invest time in reading it. This decision requires an informative description of the purpose, methods and results of the study. However, abstracts of diagnostic accuracy studies often insufficiently report such information, making it difficult for readers to appraise the potential for bias and the applicability of the study findings.
Our goal is to develop, disseminate and implement a robust reporting guideline that will help improve the informativeness of abstracts of diagnostic accuracy studies regarding essential items that are needed to evaluate elements of study validity.

SAGER (Sex and Gender Equity in Research)

The SAGER (Sex and Gender Equity in Research) is a guideline to encourage a more systematic approach to the reporting of sex and gender in research across disciplines, promoted by the EASE gender policy committee.

Reporting of orthotic (splinting) interventions

This guideline is intended as an extension or add-on to other guidelines for specific research designs. It addresses how orthotic interventions should be reported within the context of any given quantitative study design.

Reporting guidelines for implementation research and operational research

Implementation research involves increasing access to health products and strategies that are already available and have been shown to work but remain beyond the reach of many of the people who could benefit from them. It is rooted in the identification of practical problems facing disease control programmes and in finding solutions which improve access to health interventions and lead to better health outcomes. Different research methods may be used depending on the type of problem studied.

Operational research uses an existing resource – the data routinely collected by programmes – to provide ways of improving programme operations and thereby delivering more effective, efficient and equitable care. Implementation and operational research are usually carried out in close collaboration between researchers and disease control programme staff.

Reporting of Home Visiting Effectiveness/Efficacy Research (RoHVER)

This project aims to develop a comprehensive set of reporting guidelines for home visiting that improve and enhance the accuracy of reporting home visiting intervention evaluations. Specifically, the reporting guidelines focus on: (1) reporting effectiveness and efficacy studies, (2) incorporation of study designs endorsed by the Home Visiting Effectiveness of Evidence (HomVEE), and (3) inclusion of more thorough guidelines for reporting home visiting intervention design and implementation data.

COS-STAR: a reporting guideline for studies developing core outcome sets

PRISMA-RR 2017: an extension to PRISMA for rapid reviews

This reporting guideline will address reporting for rapid reviews, including those with analogous terminology (e.g., rapid evidence synthesis, rapid knowledge synthesis).

  • Protocol is forthcoming. The reporting guideline will be based on the EQUATOR guidance for developing reporting guidelines (PLoS Med 2010;7(2):e1000217).
  • Contact: Adrienne Stevens, adstevens@ohri.ca

PRISMA-DTA: Checklist for reporting of diagnostic test accuracy systematic reviews

The objective is to develop and implement a guideline for reporting diagnostic test accuracy systematic reviews and meta-analyses – Preferred Reporting Items for Systematic reviews and Meta-Analysis of Diagnostic Test Accuracy (PRISMA-DTA).

Instrument for the Selection of Primary Endpoints in Clinical Trials (InSPECT) – An evidence and consensus based reporting tool

A new evidence and consensus based reporting checklist for primary outcomes in clinical trial protocols and reports is currently under development. Clinical trialists, evidence end-users including systematic reviewers, and those involved in reporting guidelines development would be major beneficiaries of this checklist. It is the next step forward in current efforts to produce and harmonize transparent and reproducible RCT protocols and reports.

SPIRIT Extension for N-of-1 Trial Protocols (SPENT)

SPENT will extend the SPIRIT Statement (Standardized Protocol Items: Recommendations for Interventional Trials) to the reporting of individual and series N-of-1 trial protocols.

Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR)

The objective is to develop a guideline to standardize the reporting of scoping reviews – Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR).

PRISMA-CI: Reporting Guidelines for Systematic Reviews of Complex Interventions

The Complex Interventions Workgroup aimed to develop PRISMA-CI as a stand-alone extension to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement. Development of PRISMA-IPD followed the EQUATOR Network framework guidance and used the existing standard PRISMA Statement as a starting point to draft additional relevant material. The statement development process included a literature review; interviews; and a modified Delphi process of international experts including researchers, clinicians, health system delivery representatives, methodologists, journal editors, reviewers, and funders; in-person conference discussions; iterative refinements of workgroups and an advisory group, and the Complex Interventions Workgroup reached agreement on the PRISMA-CI checklist by consensus.

  • Additional information: This PRISMA-CI is part of a special series on Complex Interventions for the Journal of Clinical Epidemiology, the last of seven papers.
  • Contact: Makalapua L. Motu’apuaka, Makalapua.motu’apuaka@va.gov

 

 

When guideline development is completed and the guideline is published we will remove it from this list and include it in our database of reporting guidelines.

Please do let us know about relevant projects; it will avoid duplication of the process and might also help you to find new collaborators. To register your reporting guideline under development please complete our brief registration form (Word document).

 

Page last updated on: 10 February 2016

 

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.

Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.